Massachusetts General Hospital
Appointed in 2017
Read more
Massachusetts General Hospital
Appointed in 2017
Molecular oxygen presents a fundamental biological problem: it is vital for life, yet also incredibly toxic. As the terminal electron acceptor in aerobic respiration and the redox engine of mitochondria, oxygen provides eukaryotes with the vast majority of their energy. However when molecular oxygen is reduced it can form damaging reactive species, and recent work has demonstrated that animals with genetic lesions in the mitochondrial respiratory chain are extremely vulnerable to oxygen toxicity. How animals have evolved to manage this double-edged sword remains a fundamental question._x000D_
The biology and natural ecology of the nematode C. elegans make it an attractive system in which to study oxygen tolerance. Wild type C. elegans are tolerant of oxygen concentrations ranging from 1% to 100%, and years of genetic studies have generated a rich toolbox of mitochondrial mutants. I will use these mutants to study the biology of oxygen tolerance, which may simultaneously shed light on the connection between mitochondrial disease and oxygen toxicity.
Massachusetts General Hospital
Appointed in 2005
Read more
Massachusetts General Hospital
Appointed in 2005
Brigham and Women's Hospital
Appointed in 2020
Read more
Brigham and Women's Hospital
Appointed in 2020
Ubiquitylation is a post-translational modification that regulates the stability of thousands of proteins in our cells. The specificity for ubiquitylation is typically conferred by E3 ubiquitin ligases that attach ubiquitin onto substrate proteins. Despite the critical role that ubiquitylation plays in regulating the abundance and activity of many proteins, most ubiquitylation pathways are still poorly understood and many of the estimated ~600 E3 ubiquitin ligases have no known protein substrates.
Our lab has developed the Global Protein Stability (GPS) assay, which is a way to rapidly monitor protein stability using fluorescent proteins. We have recently been adapting this approach for library-on-library genetic screens in order to map, in parallel, dozens of ubiquitylation substrates to their cognate E3 ubiquitin ligases. We have also been using GPS screens to find degradation pathways specific to particular intracellular compartments. Together, these approaches will shed light on ubiquitylation pathways that are important for human health.
University of Cambridge, England
Appointed in 1957
Read more
University of Cambridge, England
Appointed in 1957
University of California, Santa Barbara /
Scripps Research Institute
Appointed in 1985
Read more
University of California, Santa Barbara / Scripps Research Institute
Appointed in 1985
Dana-Farber Cancer Institute
Appointed in 2021
Read more
Dana-Farber Cancer Institute
Appointed in 2021
Long interspersed element-1 (LINE-1) is the only active, protein-coding transposon in humans. LINE-1 overexpression and LINE-1 retrotransposition are hallmarks of human cancers, although the impact of LINE-1 activity on cancer genomes and cancer cell growth remains poorly understood. My research focuses on addressing the hypothesis that LINE-1 retrotransposition causes substantial gross genome instability in cancers. Supporting this hypothesis, a recent pan-cancer analysis demonstrated associations between somatically-acquired LINE-1 insertions and segmental copy-number changes. Moreover, our lab recently identified that the Fanconi anemia/ BRCA pathway is required for growth of LINE-1(+) cells, suggesting that this DNA repair pathway might limit genotoxic effects of LINE-1. I am developing several approaches to assess the impact of LINE-1 on genome integrity, and I am evaluating the contribution of the FA/ BRCA pathway to LINE-1-associated DNA damage. These studies will be the first to evaluate the scope of LINE-1-mediated genome instability and should inform efforts to exploit LINE-1 genotoxicity as a cancer therapeutic strategy.
Harvard University Medical School
Appointed in 2008
Read more
Harvard University Medical School
Appointed in 2008
The sleep disorder narcolepsy is caused by the degeneration of hypocretin neurons. The goal of my research is to derive hypocretin neurons from narcoleptic patients to study the cause of hypocretin neuron loss.
I was born in Konstanz, Germany and moved to Minnesota at an early age. As a teenager, I decided I wanted to become a neurosurgeon and spent my summers in a neurosurgery laboratory. I discovered I preferred working at the bench and, as an undergraduate at Caltech, I explored different fields of neuroscience. I was most fascinated by the problem of how the brain develops, and studied the lineage and organization of neural stem cells and their progeny in the postnatal brain. My current work combines my interests in cell type specification, the connection of circuitry to behavior, and developing in-vitro models of human diseases. In my free time, I enjoy hiking, cycling, cooking, and bartending.
Institut Pasteur, France
Appointed in 1973
Stanford University /
MRC Center, University Medical School, UK
Appointed in 1973
Read more
Stanford University / MRC Center, University Medical School, UK
Appointed in 1973
New York University
Appointed in 2017
Several vertebrate species have the astonishing ability to regenerate their limbs following amputation. In mammals, including both mice and humans, this regenerative capability has been restricted to the digit tip. Both digit tip and complete limb regeneration follow a stereotypic process termed epimorphic regeneration where a population of progenitor cells, termed the blastema, form at the injury site to replace the multiple tissues lost (including blood vessels, nerves, bone, etc.). Several studies have demonstrated that macrophages are essential for epimorphic regeneration. However, it remains largely unknown how macrophages facilitate blastema rather than scar formation. Utilizing the mouse digit tip, which displays regenerative or scarring outcomes dependent on amputation site, we are functionally testing which immune cell types uniquely contribute to epimorphic regeneration. Furthermore, by combining diverse genetic tools with intravital imaging, we are beginning to understand how injury-induced inflammation yields a permissive tissue environment for epimorphic regeneration in mammals.
University of California, San Francisco
Appointed in 2009
Read more
University of California, San Francisco
Appointed in 2009
Harvard University Medical School
Appointed in 2017
Read more
Harvard University Medical School
Appointed in 2017
DNA interstrand cross-links (ICLs) covalently connect the two strands of DNA, thereby blocking essential processes including DNA replication and transcription. Cells have evolved intricate pathways to repair ICLs and other DNA lesions to ensure genome integrity. In the Walter laboratory, we use egg extracts from the African clawed frog Xenopus laevis to biochemically dissect the molecular events during DNA replication and repair. Importantly, these and other processes are faithfully recapitulated in this highly tractable cell-free system._x000D_
_x000D_
My current work focuses on how different lesions, including ICLs, are repaired in a transcription-dependent manner. Although Xenopus egg extracts are generally considered to be transcriptionally quiescent, I set out to develop an in vitro transcription system to eventually investigate transcription-coupled DNA repair pathways of chemically distinct lesions. My study aims to biochemically characterize the underlying mechanisms as well as to identify novel factors involved in transcription-coupled DNA repair._x000D_
Stanford University
Appointed in 1977
Rockefeller University
Appointed in 2016
My research interest is to harness the power of immune system to combat cancer. This goal requires sophisticated understanding in both immunology and cancer biology. My prior graduate training has equipped me with extensive knowledge in immunology, and showed me how the immune system evokes robust and multilayered responses to defend our body against infections. However, compared to the vigorous response to infections, the immune system often becomes incompetent when it encounters cancer, especially malignant tumors. My goal during the fellowship period is to develop a cancer model in which I can trace the co-evolution between tumor-initiating stem cells and immune system, ultimately to the point of evasion of immune surveillance, so that I can identify the root of the blunted ant-tumor immune response during the cancer progression. With Dr. Fuchs’ expertise in epithelial stem cells and cancers, and my background in immunology, I feel that I’m uniquely poised to tackle this fascinating problem.
University of California, San Francisco
Appointed in 1983
Read more
University of California, San Francisco
Appointed in 1983
Scripps Research Institute
Appointed in 2006
Massachusetts Institute of Technology
Appointed in 1990
Read more
Massachusetts Institute of Technology
Appointed in 1990
Harvard University
Appointed in 1986
Harvard University Medical School
Appointed in 1998
Read more
Harvard University Medical School
Appointed in 1998
University of California, Berkeley
Appointed in 2000
Read more
University of California, Berkeley
Appointed in 2000
Stanford University School of Medicine
Appointed in 2002
Read more
Stanford University School of Medicine
Appointed in 2002
Cold Spring Harbor Laboratory
Appointed in 1993
Read more
Cold Spring Harbor Laboratory
Appointed in 1993
Rockefeller University
Appointed in 1967
California Institute of Technology
Appointed in 2010
Read more
California Institute of Technology
Appointed in 2010
I am investigating mechanisms of mitochondrial fusion within cells. The goal is to gain a better understanding of how mitochondrial dynamics are regulated.
My interest in scientific research began when I was young, and was fostered through participation in research programs and science fairs in junior high and high school. ¬†After completing my bachelor’s degree in biochemical sciences at Harvard University, I worked briefly for a biotechnology company developing treatments for patients suffering from rare genetic disorders. ¬†I then entered an MD/PhD program the University of Texas Southwestern Medical Center, allowing me to conduct basic science research while receiving training in patient care. ¬†I currently conduct research as a postdoctoral fellow at the California Institute of Technology, and plan to establish my own basic science laboratory in the future.
University of California, San Francisco
Appointed in 1998
Read more
University of California, San Francisco
Appointed in 1998
University of California, Berkeley
Appointed in 2016
Read more
University of California, Berkeley
Appointed in 2016
Yale University
Appointed in 1981
Yale University
Appointed in 2004
University of California, San Diego
Appointed in 2015
Read more
University of California, San Diego
Appointed in 2015
Yale University
Appointed in 1963
Rockefeller University
Appointed in 2014
Read more
Rockefeller University
Appointed in 2014
University of California, Berkeley
Appointed in 2015
Read more
University of California, Berkeley
Appointed in 2015
Just like people, cells have to deal with stress. I study how stressed cellular organelles such as mitochondria communicate with the nucleus, and how this stress response is coordinated in normal settings and dysregulated in disease._x000D_
_x000D_
I studied genetics as an undergraduate at the University of California, Berkeley, and then worked at Sangamo BioSciences to help develop human genome editing with engineered nucleases. I was then an NSF Fellow in the Tetrad PhD program at the University of California, San Francisco, where I worked in Christine Guthries laboratory. There, I studied how pre-mRNA splicing is regulated in particular, how the cell coordinates a pre-mRNAs transcription and its splicing. My interest in how discrete molecular processes are integrated inside the cell continues during my postdoctoral fellowship in Andrew Dillins laboratory, where I am studying a remarkable pathway called the mitochondrial unfolded protein response. In this pathway, nuclear-encoded mitochondrial protein chaperones are upregulated in response to signals from mitochondria experiencing proteotoxic stress. I am using a disease-in-a-dish model that combines human stem cell technology with genome editing approaches.
University of Oregon
Appointed in 1988
Rockefeller University
Appointed in 2011
Harvard University
Appointed in 2015
My research investigates the neural circuits that control instinctive behavior. Previously, my work focused on the innate active sensing behaviors of rodents that dominate exploration and social interactions. This work has led me to focus on questions that involve the nature of the motivational and descending drives that enable animals to generate robust and instinctive motor patterns in the appropriate context. With the expertise of the Dulac Laboratory, I hope to provide insight into these questions by defining the roles of specific, molecularly-defined cell types and neuronal circuit connectivity patterns that relate to such control. I hope to provide a unique perspective that stems from a background in engineering and the neural control of movement.
University of Utah
Appointed in 2019
The ability of cells and organisms to sense and respond to change is fundamentally driven by dynamic interactions between many different types of molecules. Although we understand some of these interactions, there are many to be uncovered.
I am investigating the landscape of RNA-metabolite interactions and their role in gene regulation. Although RNAs and small molecules can form specific and high-affinity interactions, we know effectively nothing of the RNA-metabolite interactome that might be present in eukaryotic cells. Using RNA-structure probing technologies coupled with high-throughput sequencing, I am studying a broad pool of human RNAs in various metabolic contexts, which will uncover the scope of interactions between human RNAs and human metabolites, identify the specific RNA-metabolite interactions that do occur, and allow us to test the role of these interactions in gene regulation. In complement to this approach, we have developed a screening platform to simultaneously measure the affinity between specific RNAs and 450+ human metabolites. This platform has allowed for rapid, targeted screening of viral RNAs that might sense host metabolism via RNA-metabolite interactions and can be applied to any RNA of interest.
Yale University
Appointed in 1988
University of Connecticut Health Center
Appointed in 1975
Read more
University of Connecticut Health Center
Appointed in 1975
University of California, San Francisco
Appointed in 2019
Read more
University of California, San Francisco
Appointed in 2019
Harvard University Medical School
Appointed in 1998
Read more
Harvard University Medical School
Appointed in 1998
University of California, Berkeley
Appointed in 1983
Read more
University of California, Berkeley
Appointed in 1983
University of California, Davis
Appointed in 1958
Harvard University
Appointed in 2015
I received my BS in Biochemistry from Susquehanna University and my Ph.D. in molecular biophysics in Professor Scott Baileys lab at Johns Hopkins University. Broadly speaking, I am interested in exploring the structure-function relationship of biological macromolecules. For my Ph.D. thesis, I used different structural and biochemical methods to investigate the mechanism by which bacteria use their CRISPR immune system to destroy foreign DNA._x000D_
_x000D_
In my postdoc with Professor Sunney Xie at Harvard University, my research focuses on the effects of chromatin structure on eukaryotic gene expression. More specifically, I am interested in understanding the dynamics of DNA supercoiling at a single-cell level. Outside the lab, I enjoy playing soccer and going on hikes.
Johns Hopkins University /
The Salk Institute for Biological Studies
Appointed in 1995
Read more
Johns Hopkins University / The Salk Institute for Biological Studies
Appointed in 1995
University of Dundee, Scotland
Appointed in 1987
Read more
University of Dundee, Scotland
Appointed in 1987
Yale University
Appointed in 1944
Princeton University
Appointed in 1994
University of Washington
Appointed in 2004
Harvard University
Appointed in 1981
Johns Hopkins University
Appointed in 1998
University of Wisconsin, Madison
Appointed in 1988
Read more
University of Wisconsin, Madison
Appointed in 1988